![Mark Ungs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Mark Ungs is the founder of InterValve, Inc. which he founded in 2008 and where he currently holds the titles of President, Chief Executive Officer & Director.
Mr. Ungs is also the founder of ACTx, Inc. (Georgia).
He previously worked as Vice President-New Business Development at Boston Scientific Corp.
Mr. Ungs completed his undergraduate degree at Oregon State University and earned an MBA from the University of California, Berkeley.
Postes actifs de Mark Ungs
Sociétés | Poste | Début |
---|---|---|
InterValve, Inc.
![]() InterValve, Inc. Medical SpecialtiesHealth Technology InterValve, Inc. operates as a medical device company which develops aortic valvuloplasty balloons for treatment of calcific aortic stenosis. Its V8 product is enhanced with leaflet hyperextension without increasing the risk of annulus over-distension. The firm also develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded by Wes Pedersen, Mark Ungs, Robert S. Schwartz and Robert A. Van Tassel in 2008 and is headquartered in Plymouth, MN. | Fondateur | 01/01/2008 |
ACTx, Inc. (Georgia) | Fondateur | - |
Anciens postes connus de Mark Ungs
Sociétés | Poste | Fin |
---|---|---|
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Formation de Mark Ungs
Oregon State University | Undergraduate Degree |
University of California, Berkeley | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
InterValve, Inc.
![]() InterValve, Inc. Medical SpecialtiesHealth Technology InterValve, Inc. operates as a medical device company which develops aortic valvuloplasty balloons for treatment of calcific aortic stenosis. Its V8 product is enhanced with leaflet hyperextension without increasing the risk of annulus over-distension. The firm also develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded by Wes Pedersen, Mark Ungs, Robert S. Schwartz and Robert A. Van Tassel in 2008 and is headquartered in Plymouth, MN. | Health Technology |
ACTx, Inc. (Georgia) |